Skip to main content
Log in

Pravastatin intervention trial on carotid artery atherosclerosis in patients with mild hypercholesterolemia: the CAIUS study

  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Abstract

The Carotid Atherosclerosis Italian Ultrasound Study (CAIUS) is a multicenter double-blind, placebo-controlled randomized investigation of the effects of Pravastatin on progression of asymptomatic carotid atherosclerosis in outpatients with moderate hypercholesterolemia and without symptoms or signs of coronary heart disease. Intima-Media Thickness changes of the carotid arteries will be evaluated by B-mode ultrasound imaging. This method allows the detection and monitoring of early lesions and their evolution over time. The study involves approximately 305 patients with moderate hypercholesterolemia, and at least one asymptomatic and uncomplicated early carotid artery lesion. Randomized subjects are in the age range between 45 and 65 yrs. For women a natural or artificial menopause was mandatory. The subjects were randomized to receive either a placebo or an HMG CoA reductase inhibitor (Pravastin 40 mg OD), known to act selectively and primarily on liver cholesterol biosynthesis. The patient follow-up of CAIUS will have a duration of at least 36 months. Every 6 months participating subjects are being monitored by B-mode ultrasound as described in the protocol requiring training and certification of sonographers/readers and centralized reading. The study offers a unique opportunity to monitor the natural history of asymptomatic carotid lesions in hypercholesterolemic patients, as well as to evaluate the effect of a potent cholesterol-lowering medication on progression or regression of carotid atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Levy RI, Brensike JF, Epstein SE, et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: Results of NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 325–37.

    PubMed  Google Scholar 

  2. Arntzenius AC, Kromhout D, Barth JD, et al. Diet, lipoproteins and the progression of coronary atherosclerosis: The Leiden Intervention Trial. N Engl J Med 1985; 312: 805–11.

    PubMed  Google Scholar 

  3. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effect of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257: 3233–40.

    PubMed  Google Scholar 

  4. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264: 3007–12.

    PubMed  Google Scholar 

  5. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289–98.

    PubMed  Google Scholar 

  6. Ricotta JJ. Plaque characterization by B-mode scan. Surg Clin North Am 1990; 70: 191–9.

    PubMed  Google Scholar 

  7. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399–406.

    PubMed  Google Scholar 

  8. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988; 70: 253–61.

    PubMed  Google Scholar 

  9. Craven TE, Ryu JE, Espeland MA, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation 1990; 82:1230–42.

    PubMed  Google Scholar 

  10. Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke: The Framinghan Study. JAMA 1983;250: 2942–6.

    PubMed  Google Scholar 

  11. Komrad MS, Coffey CE, Coffey KS, McKinnis R, Massey EW, Califf RM. Myocardial infarction and stroke. Neurology 1984;34: 1403–9.

    PubMed  Google Scholar 

  12. Barnes RW, Liebman PR, Marszalek PB, Kirk CL, Goldman MH. The natural history of asymptomatic carotid disease in patients undergoing cardiovascular surgery. Surgery 1981; 90: 1075–83.

    PubMed  Google Scholar 

  13. Di Pasquale G, Andreoli A, Pinelli G, et al. Cerebral ischemia and asymptomatic coronary artery disease: A prospective study of 83 patients. Stroke 1986; 17: 1098–1101.

    PubMed  Google Scholar 

  14. Insull W, Bond MG, Wilmoth SK, Fishel J, Herson J. Ultrasound lesions of the carotid artery and risk factors in men. In: Glagow S, et al., (ed). Pathobiology of the human atherosclerotic plaque. New York: Springer Verlag, 1988:663–70.

    Google Scholar 

  15. Bond MG, Strikland HL, Wilmoth SK, Safrit A, Phillips R, Szostak L for MIDAS Group. Interventional clinical trials using noninvasive ultrasound end points: The Multicenter Isradipine/Diuretic Atherosclerosis Study. J Cardiovasc Pharmacol 1990; 15 (Suppl 1): S30-S33.

    Google Scholar 

  16. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600–4.

    PubMed  Google Scholar 

  17. Sirtori CR. Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitors. Pharmacol Res 1990; 22: 555–63.

    PubMed  Google Scholar 

  18. Crepaldi G, Baggio G, Arca M, et al. Pravastatin vs. gemfibrozil in the treatment of primary hypercholesterolemia. Arch Intern Med 1991; 151:146–52.

    PubMed  Google Scholar 

  19. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–552.

    PubMed  Google Scholar 

  20. Roschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamt-Cholesterins in Serum. Z Klin Chem Klin Biochem 1974;12: 403–7.

    PubMed  Google Scholar 

  21. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19: 476–82.

    PubMed  Google Scholar 

  22. Navalesi R, Benzi L, Paci A, et al. Misura del colesterolo HDL in soggetti umani campionati in due diverse regioni italiane. G. dell'Arteriosclerosi 1979; 3: 270–4.

    Google Scholar 

  23. Gotto AM Jr, Farmer JA. Risk factors for coronary artery disease. In: Braunwald E, (ed). Heart disease: A textbook of cardiovascular medicine, 3rd Ed, Vol 2. Philadelphia: W.B. Saunders, 1988: 1153–90.

    Google Scholar 

  24. Loscalzo J. Regression of coronary atherosclerosis. N Engl J Med 1990; 323: 1337–9.

    PubMed  Google Scholar 

  25. Yoshida K, Yoshikawa J, Hozumi T, et al. Detection of left main coronary artery stenosis by transesophageal color Doppler and two-dimensional echocardiography. Circulation 1990;81: 1271–6.

    PubMed  Google Scholar 

  26. Poli A, Colombo A, Tremoli E, Pignoli P. Spontaneous progression of small carotid atheroma detected by echotomography. Lancet 1985; ii: 559–60.

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sirtori, C.R., Bianchi, G., Bond, M.G. et al. Pravastatin intervention trial on carotid artery atherosclerosis in patients with mild hypercholesterolemia: the CAIUS study. Int J Cardiac Imag 11 (Suppl 2), 119–124 (1995). https://doi.org/10.1007/BF01419825

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01419825

Key words

Navigation